Additionally, CD33+CD14− PMN‐MDSC levels increased in patients with larger tumors, whereas CD11b+CD14+/CD33+CD14+ M‐MDSC levels decreased in those with lymphatic tumor emboli. This evidence concerns the gene CD33 and neoplasm.